Johnson & Johnson Hit With $117 Million in Asbestos Talcum Powder Trial

Posted on 04/24/2018Back

On Thursday, April 5, a New Jersey state court jury sided with plaintiff Stephen Lanzo III and his wife over claims that Johnson & Johnson and its talc supplier, Imerys Talc America Inc., sold and distributed asbestos-containing talcum powder which contributed to Lanzo’s development of mesothelioma, a rare and aggressive form of lung cancer caused by asbestos. The jury awarded $37 million to Lanzo in compensatory damages, and on Wednesday, April 11, the jury awarded an additional $80 million in punitive damages.


Arguments from Plaintiffs and Defendants focused on the nature of the testing done on Johnson & Johnson’s talcum powder. Defendants argued that asbestos was never found in Imerys’ talc mines or in J&J’s product. Plaintiffs argued that J&J manipulated the testing method so that asbestos could not be found in order to allow the company to certify that asbestos was never found. Ultimately, the jury sided with the Plaintiffs, finding that Stephen Lanzo III’s decades-long usage of talcum powder contributed to his contracting mesothelioma.


On Wednesday, April 11, the jury found that the Defendants acted with reckless indifference in selling and distributing the asbestos-containing talcum powder. The jury determined the additional punitive damages were warranted because J&J and Imerys acted deliberately and with disregard to the rights of Stephen Lanzo III and his wife. They awarded $55 million against J&J and $25 million against Imerys.


GoldenbergLaw is accepting talcum powder cases in which an individual was diagnosed with ovarian cancer and mesothelioma after years of extensive talcum powder usage. If you or a loved one has been diagnosed with ovarian cancer and used talcum powder, please contact GoldenbergLaw for a free case evaluation. There’s no fee unless we recover. Call us at 612 – 436 – 5026.

Category Dangerous Drugs